All News

KOL Views: How much of a threat is Pfizer’s abrocitinib in atopic dermatitis?
Ref: KOL Views Desk
Tags: KOL ViewsAbbVie Lilly Pfizer RegeneronDermatitis FDAMarketing & Sales Medical Affairsabrocitinib Dupixent Olumiant upadacitinib
ViewPoints: ProQR pleads its case in LCA10 ahead of CRISPR data debut
Ref: ViewPoints Desk
Tags: ViewPointsProQR Therapeutics Editas Medicine Allergan Clinical Research (R&D) Medical AffairsSepofarsen EDIT-101
ViewPoints: Alexion dealmaking could prove a little too complementary
Ref: ViewPoints Desk
Tags: ViewPointsAchillion Alexion Apellis Pharmaceuticals Ra Pharmaceuticals UCB Corporate Affairs Mergers & AcquisitionsSoliris Ultomiris danicopan
Mogrify Raises Additional $16 Million to Advance its Mission to Transform the Development of Life-saving Cell Therapies
Ref: Business Wire
Tags: Press ReleaseMogrify Corporate Affairs
Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Ref: GlobeNewswire
Tags: Press ReleaseSunesis Clinical Research (R&D) Medical AffairsAACR-NCI-EORTCSNS-510
Diabetes: A next-generation therapy soon available?
Ref: Université de Genève
Tags: Press ReleaseDiabetes Clinical Research (R&D)S100A9
VHIO: driving the development of pioneering cell therapies for non-responders to current immunotherapies
Ref: Vall d'Hebron Institute of Oncology
Tags: Press Release Clinical Research (R&D)
Hormone Therapy Associated With Improved Cognition
Ref: The North American Menopause Society (NAMS)
Tags: Press ReleaseMenopause HRT Clinical Research (R&D)
Kura Oncology Announces Upcoming Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Ref: GlobeNewswire
Tags: Press ReleaseKura OncologyHead and Neck Cancer Clinical Research (R&D) Medical AffairsAACR-NCI-EORTCtipifarnib
Regulus Therapeutics Presents Preclinical Data Identifying RGLS4326 as a Potential Disease-Modifying Treatment for Autosomal Dominant Polycystic Kidney Disease at OTS Annual Meeting
Ref: PR Newswire
Tags: Press ReleaseRegulus Clinical Research (R&D) Medical AffairsOTS Annual MeetingRGLS4326